The report provides market dynamics and trends related to the global electroencephalography equipment market. In addition, it presents the market estimations and forecast of the market. For the purpose of analysis, the global electroencephalography equipment market has been segmented based on product, application, end users and region. The report includes the revenue generated from the sales of products such as integrated EEG systems, portable EEG systems and EEG accessories, which are used for performing electroencephalograms. However, the report does not include revenue generated from the services provided by companies that conduct electroencephalograms. Moreover, for a further clarification the report also provides a broad view of the applications of the EEG products such as brain monitoring, sleep monitoring, and anesthesia monitoring, research and others. The market is also classified into end users such as hospitals, diagnostic centers, ambulatory surgical centers and others that utilize the products. This further provides the understanding about the use of EEG products. Furthermore, the report covers revenue generated from the sales of products related to electroencephalography equipment offered in regions such as North America, Europe, Asia-Pacific, and LAMEA

Exosomes have promising potential to be as a vehicle for drug delivery as they have natural material transportation properties, the capability of intrinsic long-term circulation, and high biocompatibility, which are the most suitable factors for the delivery of a variety of proteins, chemicals, and nucleic acids. Certain factors that are driving the market growth include rising prevalence of cancer, technological advancements in exosomes isolation and analytical procedures, increasing government initiatives and funding for exosome research, and increasing advanced applications of exosomes. The growing prevalence of cancer patients has a direct impact on the increased demand for the exosomes market. Exosomes extracted from cow milk is being used for the delivery of therapeutic molecules against lung and breast cancers.

The major factors attributing to the growth of the market are the increasing number of disabling hearing loss cases, rising geriatric population indirectly contributing to increased awareness of these devices, and increasing technological advancements by the companies. As per the revised World Population Prospects, by the United Nations, the number of people aged 60 or above is expected to grow greater than double by 2050, i.e. from 962 million in 2017 to 2.1 billion in 2050, worldwide. This age group is much more vulnerable to hearing loss, which boosts the demand for these devices in the market. According to “The Global Burden of Disease Study 2017” Disease and Injury Incidence and Prevalence Collaborators report, the estimated population with hearing loss rose from 1.2 billion (17.2%) in 2008 to 1.4 billion (18.7%) in 2017, for whom proper well-coordinated global action is needed.

The growth of the epigenetics market is attributed to the increasing prevalence and incidence of cancer, increasing funding and investment for research and development in epigenetics, and growth in the applications of epigenetics in non-oncology diseases, like autoimmune diseases, metabolic diseases, and cardiovascular diseases. Cancer Research UK suggests that if recent trends in incidence of major cancers and population growth are consistent, there will be 27.5 million new cancer cases worldwide each year by 2040. This is an increase of 61.7% from 2018 and is expected to be higher among the male population (with a rise of about 67.6%) as compared to the female population (with an estimated rise of 55.3%). This has boosted the demand for novel drugs through epigenetics research that are more effective and have lesser side effects. This surging demand has increased the researches in this field as well. In the last two decades, more than 7,000 grants and a total of more than GBP 6.5 billion have been granted, worldwide, for epigenetic research, according to the Medical Research Council (MRC) of the United Kingdom.